Introduction
============

Prior to assembly on the plasma membrane (PM), the human immunodeficiency virus type-1 (HIV-1) Gag polyprotein adopts a compact "folded over" conformation and exists in the monomeric or low-order oligomeric states ([@B17], [@B16]; [@B41]; [@B42]). Whereas it is established that the nucleocapsid (NC) domain of Gag specifically recognizes motifs in the viral RNA genome for packaging ([@B39]; [@B42]), there is compelling evidence that the matrix (MA) domain also binds to cellular RNA to prevent premature Gag targeting to intracellular membranes (Figure [1](#F1){ref-type="fig"}; [@B12], [@B11]; [@B13]; [@B33]; [@B35]; [@B42]; [@B48]). Upon transport of Gag to the PM, the interaction of MA with RNA is exchanged for an interaction of MA with PM components (Figure [1](#F1){ref-type="fig"}; [@B12], [@B11]; [@B13]; [@B33]; [@B35]; [@B48]). This molecular switch induces an extended conformation of Gag, leading to formation of high-order Gag oligomers on the PM ([@B17],[@B18], [@B16]; [@B46]). The key to understanding this essential switch is elucidating at the molecular level the interaction of MA with specific PM components. Our current understanding of Gag--PM interaction is incomplete because of the lack of molecular details on how various membrane components contribute to the overall binding and how they control this molecular switch.

![**The MA domain of Gag is involved in multiple interactions including RNA and lipids on the inner leaflet of the PM**.](fmicb-06-00232-g0001){#F1}

Factors that Control HIV-1 Gag Assembly on the PM
=================================================

For most retroviruses, assembly of the Gag proteins occurs on the PM of the infected cell ([@B51]; [@B38], [@B37]; [@B25]; [@B71]; [@B10], [@B12]; [@B9]; [@B13]). The role of MA domain in Gag--PM binding is indispensable. Several factors can influence Gag--membrane binding including the myristoyl (myr) group, a conserved basic region in MA, protein multimerization, cellular RNA, and phosphatidylinositol-4,5-bisphosphate \[PI(4,5)P~2~\] ([@B52]; [@B51]; [@B38]; [@B14]; [@B10], [@B12], [@B11]; [@B1]; [@B13]; [@B29]). The finding that Gag binds to membranes more efficiently than the isolated MA protein led to the hypothesis that the myr group is exposed in Gag and sequestered in the MA protein, which has become known as "the myr switch mechanism" ([@B75]; [@B65]; [@B32]; [@B52]; [@B53]). For over two decades, biochemical, *in vivo*, *in vitro*, and genetic data have provided invaluable insights on multiple factors that modulate Gag--membrane binding. However, only recently the molecular and structural determinants of this interaction have begun to emerge ([@B60], [@B59], [@B57]; [@B63]; [@B10], [@B12], [@B11]; [@B13]; [@B55]; [@B69]). Nuclear magnetic resonance (NMR) and analytical ultracentrifugation studies revealed that the myr group can adopt sequestered and exposed conformations in the MA protein, that the MA protein resides in monomer-trimer equilibrium, and that myr exposure is coupled with protein trimerization ([@B67]; [@B59]). Exposure of the myr group is also modulated by other factors including the solution pH, inclusion of the CA domain, and binding of calmodulin ([@B67]; [@B26]; [@B28]). There is now convincing evidence that binding of RNA to MA prevents Gag from interacting with intracellular membranes ([@B12], [@B11]; [@B13]; [@B35]). As a consequence, RNA is considered as a negative regulator of Gag--membrane binding. Recent studies have shown that the MA domain binds almost exclusively to specific tRNAs in the cytosol ([@B42]). Incorporation of PI(4,5)P~2~ in membranes inhibits the interaction between MA and cellular RNA ([@B12], [@B11]; [@B13]). Binding of Gag to membranes induces an extended conformation in the absence ([@B16]) or presence ([@B18]) of inositol phosphates. Altogether, these studies indicate that particle assembly is regulated by coordinated interactions between the MA and NC domains of Gag with RNA and membrane lipids.

Structural Studies of HIV-1 MA Binding to PM Lipids
===================================================

Proper targeting of HIV-1 Gag to the PM is dependent on specific interactions between the MA domain and PI(4,5)P~2~ ([@B51]; [@B10], [@B12]; [@B13]; [@B35]). The most abundant form of PI(4,5)P~2~ contains saturated 18-carbon 1′ and 20-carbon unsaturated 2′ fatty acid chains ([@B21]), which promote micelle formation in aqueous solution ([@B36]). Interactions of HIV-1 Gag and MA with PI(4,5)P~2~ have been detected by mass spectrometric protein footprinting ([@B63]). Titration of native PI(4,5)P~2~ into MA samples led to severe broadening and loss of NMR signals. Therefore, soluble analogs of PI(4,5)P~2~ with truncated 1′- and 2′-acyl chains (C~4~ or C~8~) have been used ([@B60], [@B58], [@B57]). NMR studies have shown that soluble analogs of PI(4,5)P~2~ bind directly to HIV-1 MA, inducing a conformational change that promotes myr exposure ([@B60]). The solution structure of the MA--PI(4,5)P~2~ complex revealed that the 2′-acyl chain is inserted in a hydrophobic cleft, whereas the inositol group is packed against a highly basic region of MA (Figure [2A](#F2){ref-type="fig"}). The 1′-acyl chain, however, is not involved in binding and is exposed to solvent. It was suggested that PI(4,5)P~2~ can function as both an allosteric trigger for myr exposure and as a direct membrane anchor ([@B60]). The involvement of the acyl chain of PI(4,5)P~2~ in MA and Gag binding has been confirmed by surface plasmon resonance methods ([@B3]). Based on the NMR studies, a structural model for Gag bound to PM has been proposed. In this model, MA is anchored to the membrane by the myr group and 1′-acyl chain of PI(4,5)P~2~, which bracket a patch of conserved basic residues that can interact with the negatively charged surface of PM ([@B60]). A molecular model of MA bound to native PI(4,5)P~2~ shows that a longer 2′-acyl chain (18 carbons) can be accommodated into the hydrophobic cleft ([@B60]). Structural studies have yet to determine the precise mode of MA binding to native PI(4,5)P~2~ within the context of a membrane bilayer.

![**(A--D)** Close-up views of structures of HIV-1, HIV-2, and M-PMV MA proteins bound to lipids. MA proteins are shown in ribbon and surface representations with residues implicated in binding shown as sticks. Phospholipids are shown as green \[PI(4,5)P~2~\] or blue (PC) sticks and their acyl chains involved in binding are shown in cyan. **(A)** HIV-1 myr(--)MA bound to di-C~8~-PI(4,5)P~2~ (PDB ID: 2H3V). **(B)** HIV-1 myr(--)MA bound to di-C~8~-PC (PDB ID: 2LYA). **(C)** HIV-2 MA bound di-C~4~-PI(4,5)P~2~ (PDB ID: 2K4I). **(D)** M-PMV MA bound to di-C~8~-PI(4,5)P~2~ structure provided by [@B55]. **(E)** Cryoelectron microscopy reconstruction of HIV-1 immature particle in a section with (left) or without (right) Gag polyprotein present. Used with permission \[Copyright (2009) National Academy of Sciences, USA ([@B5])\]. **(F)** A schematic representation of potential mechanisms for Gag binding to the PM for different retroviruses. Gag binding to membranes is regulated by PI(4,5)P~2~ and RNA for some but not all retroviruses. Binding of Gag to membranes via the MA domain displaces RNA, which binds non-specifically to the basic region of MA. Data are not in agreement on the role of PI(4,5)P~2~ in MLV Gag binding to the PM. For EIAV, Gag binding to membranes appears to have no specific requirement for PI(4,5)P~2~ since other phosphoinositides may also play a role. For M-PMV, Gag assembly occurs in the cytoplasm prior to transport to the PM where MA specifically recognizes PI(4,5)P~2~.](fmicb-06-00232-g0002){#F2}

In addition to PI(4,5)P~2~, other lipids have been implicated in HIV-1 Gag--membrane binding ([@B14]; [@B49]; [@B70]; [@B6]; [@B13]; [@B11]). The affinity of Gag and MA to membranes is increased upon increasing the stoichiometry of phosphatidylserine (PS; [@B22]; [@B75]; [@B61]; [@B14]; [@B10], [@B12], [@B11]; [@B2]; [@B6]). NMR studies on HIV-1 MA binding to soluble analogs of PM lipids revealed that PS, phosphatidylethanolamine (PE) and phosphatidylcholine (PC) bind directly to MA via a distinct site that is adjacent to the PI(4,5)P~2~ binding site ([@B69]). All three phospholipids interact with MA via sequestration of the 2′-acyl chain into a cavity formed by hydrophobic residues in helices α2 and α3, leaving the 1′-acyl exposed (Figure [2B](#F2){ref-type="fig"}). Surprisingly, the polar heads of PE, PS, or PC do not appear to play a major role in stabilizing the complex. Structural studies have been conducted with single lipids. It is likely that in a membrane environment the lipid polar heads will orient to make favorable electrostatic contacts with the basic domain of MA. Consistent with the hydrophobic nature of binding, the affinities of all three phospholipids to MA increased by two orders of magnitude upon extending the acyl chains from hexanoyl to octanoyl ([@B69]). Intriguingly, the myr group is readily exposed when MA is bound to membrane mimetics such as micelles and bicelles in the absence of PI(4,5)P~2~. Exposure of the myr group does not appear to be triggered by an allosteric mechanism as in the case of PI(4,5)P~2~ binding, but rather by the mere presence of a lipid agglomerate. Based on these studies, we have proposed a trio engagement model by which HIV-1 Gag is anchored to the PM via the 1′-acyl chains of PI(4,5)P~2~ and PS/PE/PC lipids, and the myr group, which collectively bracket a basic patch projecting toward the polar leaflet of the membrane ([@B69]). Exposure of the myr group by a membrane-like environment, independent of PI(4,5)P~2~ binding, was also observed in a reverse micellar system ([@B68]). Spontaneous exposure of the myr group prior to association to membranes has also been observed by using coarse-grained simulation approaches ([@B7]). The authors reported that insertion of the myr group into the bilayer is necessary for the orientation of MA to allow for the experimentally identified region of MA to interact with the PI(4,5)P~2~ head group. Flipping of the lipid acyl chain out of the membrane environment to the hydrophobic groove in MA was, however, not observed. Further studies are needed to answer yet unresolved questions: What is the actual trigger and mechanism of myr exposure *in vivo*? Are acyl chains of either PI(4,5)P~2~ or other phospholipids involved in MA binding to the PM? The Vogt lab has recently shown that Gag and MA strongly preferred lipids with both acyl chains unsaturated over those with one chain unsaturated ([@B19]). Furthermore, Gag can sense cholesterol in the membrane bilayer allowing for a more efficient Gag binding to membranes ([@B19]). However, it is not yet known whether cholesterol can bind directly to Gag. Recent studies have also suggested that interactions can occur between the isolated NC and p6 domains of Gag with membrane models ([@B64]; [@B40]). However, the biological significance of these interactions has yet to be established. Further studies are needed to determine the synergy and interplay between PM components and their role in modulating the conformational switch of HIV-1 Gag during assembly ([@B50]).

Other Retroviral Gag and MA Interactions with Lipids and Membranes
==================================================================

Like HIV-1, the site of HIV-2 assembly *in vivo* is also dependent on PI(4,5)P~2~ ([@B57]). Structural studies show that the HIV-1 and HIV-2 MA structures are very similar and that PI(4,5)P~2~ binds to both proteins in an identical manner (Figures [2A](#F2){ref-type="fig"},[C](#F2){ref-type="fig"}; [@B57]). However, in contrast to HIV-1 MA the position of the myr group in HIV-2 MA is less sensitive to factors that modulate myr exposure in HIV-1 MA such as protein concentration and binding of di-C~4~-PI(4,5)P~2~ ([@B57]). Data are not in agreement on the role of PI(4,5)P~2~ in other retroviruses. Previous studies have shown that murine leukemia virus (MLV) Gag targeting to the PM is mediated by PI(4,5)P~2~ and PS, suggesting a synergy between these two lipids to modulate Gag--PM binding ([@B30]). The Ono laboratory, however, has recently shown that MLV Gag--PM binding is not dependent on PI(4,5)P~2~ ([@B35]). The Gag proteins of Rous sarcoma virus (RSV) and equine infectious anemia virus (EIAV) lack the myr group and it is thought that Gag--membrane interaction is driven mainly by electrostatic interactions ([@B23]; [@B56]; [@B15]; [@B8]; [@B24]). Association of RSV MA and Gag with liposomes of defined composition is dependent on the presence of a biologically relevant concentration of negatively charged lipids like PS ([@B15]). The Vogt laboratory has shown that RSV Gag has no specific requirement for PI(4,5)P~2~ for PM association *in vivo* or liposome interaction *in vitro* ([@B6]). Parent and colleagues, however, have shown that depletion of intracellular PI(4,5)P~2~ and phosphatidylinositol-(3,4,5)-trisphosphate \[PI(3,4,5)P~3~\] levels impaired RSV Gag PM localization ([@B47]). It was suggested that differences are partially attributed to the sensitivity of assays utilized in these studies ([@B20]). Most recent *in vitro* and *in vivo* studies from the Ono laboratory have shown that Gag--membrane binding via RSV MA is both PI(4,5)P~2~ dependent and is susceptible to RNA-mediated inhibition ([@B35]). No structural studies are currently available on how RSV MA interacts with PM lipids.

The Carter laboratory has reported that a soluble analog of PI(4,5)P~2~ interacts directly with EIAV MA ([@B8]). More recently, it was shown that EIAV Gag is not only present on the PM but also in compartments enriched in phosphatidylinositol 3,5-biphosphate \[PI(3,5)P~2~\] ([@B24]). In contrast to HIV-1, release of EIAV particles is not significantly diminished by co-expression with 5-phosphatase IV, which may suggest that PI(4,5)P~2~ does not play a critical role in EIAV Gag assembly on the PM. Additional NMR studies have shown that phosphatidylinositol 3-phosphate \[PI(3)P\] binds to EIAV MA tighter than that of PI(4,5)P~2~ ([@B24]). Altogether, it is likely that EIAV Gag membrane targeting proceeds via a mechanism that is different from that of HIV-1, HIV-2, MLV, or RSV.

The Gag precursor of deltaretrovirus human T-lymphotropic virus type 1 (HTLV-1), Pr53Gag, localizes at the cell surface and intracellular compartments in HeLa cells ([@B45], [@B44]; [@B31]). It has been shown that subcellular localization of HTLV-1 Gag and VLP release are minimally or not sensitive to depletion of PI(4,5)P~2~ from the PM, suggesting that the interaction of HTLV-1 MA with PI(4,5)P~2~ is not essential for HTLV-1 Gag--membrane binding and particle assembly ([@B34], [@B35]). Single amino acid substitutions that confer a large basic patch rendered HTLV-1 MA susceptible to the RNA-mediated block, a phenotype similar to that observed for HIV-1 and RSV. It remains unknown whether other PM lipids play important roles in HTLV-1 Gag assembly as further studies are needed to identify the precise molecular requirements for HTLV-1 Gag binding to membranes.

Assembly and particle production of Mason-Pfizer monkey virus (M-PMV) is perhaps the most distinct from all cases discussed above. M-PMV is thought to catalyze the membrane envelopment of a preassembled spherical capsid shell to release infectious virions ([@B62]). Assembly of M-PMV capsids occurs in a pericentriolar region of the cytoplasm prior to transport to the PM for budding. It is thought that both MA and CA domains of M-PMV Gag interact with the PM ([@B62]). Initial evidence for a potential role of PI(4,5)P~2~ in M-PMV Gag--PM binding has been reported by Hunter and colleagues ([@B66]). Depletion of PI(4,5)P~2~ from the PM led to dramatic decrease of particle release from M-PMV infected cells. Direct interaction between M-PMV MA and a soluble analog of PI(4,5)P~2~ has been detected ([@B55]). The solution structure of M-PMV MA protein and its binding mode to di-C~8~-PI(4,5)P~2~ have been determined by NMR and molecular docking methods (for more details, see [@B55], [@B54]). The hallmark of the binding mode is the deep penetration of one of the C~8~ chains into a hydrophobic pocket formed between helices α1, α2, and α4 (Figure [2D](#F2){ref-type="fig"}). The position of the myr group of M-PMV MA was not affected by di-C~8~-PI(4,5)P~2~ binding and remained sequestered in the protein core. Interestingly, no binding was detected between the unmyristoylated MA protein of M-PMV and soluble analogs of PI(4,5)P~2~ ([@B55]). The authors attributed this observation to the structural differences between MA and unmyristoylated MA, in which the hydrophobic cavity is absent in the latter. Altogether, the mechanisms of retroviral Gag assembly appear to be complex and require more detailed investigation at the molecular level (Figure [2F](#F2){ref-type="fig"}).

Gaps in Our Understanding of Gag Binding to the PM and Future Directions
========================================================================

Structural studies of HIV-1 MA interactions with PI(4,5)P~2~, PS, PE, and PC have provided novel insights into the molecular mechanism of Gag assembly on the PM. These studies have utilized lipids with truncated acyl chains. The precise mode of binding of native lipids with longer chains to MA has yet to be elucidated. The lack of an atomic snapshot for MA when bound to membranes containing physiologically relevant lipid composition remains a major gap in our understanding of virus assembly. Investigation of the molecular rearrangements of Gag in the immature and mature HIV particles have heavily relied on cryoelectron microscopy (cEM) data. Although details of the hexameric CA lattice exist, cEM studies have not provided a clear picture of the membrane-associated MA domain of Gag in either of the immature or mature particles ([@B27]; [@B4], [@B5]; [@B72]). cEM data show that the membrane bilayer is thicker in regions where the Gag lattice is present and that MA density appears to "penetrate" the membrane bilayer (Figure [2E](#F2){ref-type="fig"}; [@B5]). Earlier cEM tomography studies have suggested that the membrane-bound MA domain lacks periodicity ([@B72]). We believe that future studies may benefit from hybrid structural and biophysical methods to construct a model of Gag and/or MA bound to membranes. These may include small-angle x-ray scattering, atomic force microscopy and high-resolution cEM. Understanding the molecular basis of Gag assembly will not only shed light on the assembly of HIV-1 particles but will likely provide insight into the control of assembly in other retroviruses that assemble at the PM. Such studies are of great importance as these interactions may serve as pharmacological targets to inhibit HIV assembly. Structure-based studies have identified small molecule inhibitors that bind to the PI(4,5)P~2~ site of HIV-1 MA and possess modest potency in reducing virus production ([@B73],[@B74]; [@B43]). Although considered weak binders, these inhibitors may serve as a template for future studies aimed at the development of novel inhibitors of retroviral assembly.
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